PRCT
HEALTHCAREProcept Biorobotics Corp
AI Insight
What's Moving PRCT Today?
No stock-specific AI insight has been generated for PRCT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$19.35$62.17
$20.60
Fundamentals
Market Cap$1.1B
P/E Ratio—
EPS$-1.83
Dividend Yield—
Dividend / Share—
ROE-27.8%
Profit Margin-31.8%
Debt / Equity—
Trading
Volume2.0M
Avg Volume (10D)—
Shares Outstanding56.9M
PRCT News
22 articles- Is PROCEPT BioRobotics Corporation (PRCT) A Good Stock To Buy Now?Yahoo Finance·Jun 19, 2026
- SpaceX initiated, Intel upgraded: Wall Street's top analyst callsYahoo Finance·Jun 11, 2026
- Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More247 Wall St·Jun 11, 2026
- JenaValve Appoints Matt Bacso as Chief Financial OfficerYahoo Finance·Jun 10, 2026
- PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV Milestones - What's ChangedYahoo! Finance Canada·Jun 1, 2026
- PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE ApprovalYahoo Finance·May 28, 2026
- Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT)Yahoo Finance·May 26, 2026
- This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%Motley Fool·May 23, 2026
- 5 Robotics Stocks to Watch as Physical AI Builds MomentumMarketbeat·May 18, 2026
- PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Hold" from BrokeragesMarketBeat·May 18, 2026
- AUA Guidelines Strengthen Recommendation for Aquablation® TherapyYahoo Finance·May 14, 2026
- Q1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock OutlookYahoo Finance·May 12, 2026
- How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance ResetYahoo Finance·May 4, 2026
- PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS LaunchYahoo Finance·May 1, 2026
- PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & JuneYahoo Finance·Apr 30, 2026
- Procept (PRCT) Q1 2026 Earnings TranscriptMotley Fool·Apr 30, 2026
- PROCEPT BioRobotics Corporation Q1 2026 Earnings Call SummaryMoby·Apr 30, 2026
- PROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...Yahoo Finance·Apr 30, 2026
- PROCEPT BioRobotics Q1 Earnings Call HighlightsMarketbeat·Apr 30, 2026
- PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·Apr 29, 2026
- PROCEPT BioRobotics Reports First Quarter 2026 Financial ResultsYahoo Finance·Apr 29, 2026
- Securities Fraud Investigation Into PROCEPT BioRobotics Corporation (PRCT) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law FirmBenzinga·Apr 22, 2026
All 22 articles loaded
Price Data
Open$21.26
Previous Close$20.60
Day High$21.50
Day Low$19.92
52 Week High$62.17
52 Week Low$19.35
52-Week Range
$19.35$62.17
$20.60
Fundamentals
Market Cap$1.1B
P/E Ratio—
EPS$-1.83
Dividend Yield—
Dividend / Share—
ROE-27.8%
Profit Margin-31.8%
Debt / Equity—
Trading
Volume2.0M
Avg Volume (10D)—
Shares Outstanding56.9M
About Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. The company is headquartered in Redwood City, California.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—